menu
    • menu

    Company profile for Abdera Therapeutics

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of...
    Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiation therapies - one of the most cutting-edge and highly promising areas of drug development. The company is built on a proprietary modular technology platform optimized for the delivery of radioisotopes to selectively destroy tumor cells while sparing healthy cells. Abdera is using this platform to enable the rapid development of a broad range of safe and efficacious therapies serving cancer patients with limited treatment options.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abdera TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    535 Middlefield Road Suite 240 Menlo Park, CA 94025
    Telephone
    Telephone
    +1 (778) 200-2999
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://abderatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abdera-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abdera Therapeutics To Present At JP Morgan Healthcare Conference
    Abdera Therapeutics To Present At JP Morgan Healthcare Conference

    18 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251217640412/en/Abdera-Therapeutics-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference-on-Tuesday-January-13

    BUSINESSWIRE
    18 Dec 2025
    Share Share
    Abdera Reveals Ph 1 ABD-147 Data at IASLC 2025 Lung Cancer Meet
    Abdera Reveals Ph 1 ABD-147 Data at IASLC 2025 Lung Cancer Meet

    09 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250908680774/en/Abdera-Therapeutics-Presents-Initial-Phase-1-Clinical-Data-on-ABD-147-a-Next-generation-DLL3-targeting-Radiopharmaceutical-Therapy-at-IASLC-2025-World-Conference-on-Lung-Cancer

    BUSINESSWIRE
    09 Sep 2025
    Share Share
    Abdera to Present Ph1 ABD-147 Data at IASLC 2025 Lung Cancer Meet
    Abdera to Present Ph1 ABD-147 Data at IASLC 2025 Lung Cancer Meet

    26 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250825455176/en/Abdera-Therapeutics-to-Present-Early-Pharmacokinetics-Dosimetry-and-Safety-Data-from-Ongoing-Phase-1-Trial-of-ABD-147-at-the-IASLC-2025-World-Conference-on-Lung-Cancer-and-Participate-in-Upcoming-Investor-Conferences

    BUSINESSWIRE
    26 Aug 2025
    Share Share
    Abdera Therapeutics Names Rachael as Chief Scientific Officer
    Abdera Therapeutics Names Rachael as Chief Scientific Officer

    08 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250707182323/en/Abdera-Therapeutics-Appoints-Rachael-Brake-Ph.D.-as-Chief-Scientific-Officer

    BUSINESSWIRE
    08 Jul 2025
    Share Share
    Abdera to Present Radiopharmaceutical Updates at AACR Meeting
    Abdera to Present Radiopharmaceutical Updates at AACR Meeting

    23 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250422477079/en/Abdera-Therapeutics-to-Present-Key-Updates-on-its-Radiopharmaceutical-Development-Pipeline-at-the-2025-American-Association-for-Cancer-Research-AACR-Annual-Meeting

    BUSINESSWIRE
    23 Apr 2025
    Share Share
    Abdera To Present At 43rd J.P. Morgan Healthcare Conference
    Abdera To Present At 43rd J.P. Morgan Healthcare Conference

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250108635978/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search